Guru Ownership Trend
Guru Analysis for DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.61 M.
Top institutional holders include Leon Cooperman and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $189,864.92 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 68.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for DiaMedica Therapeutics Inc. (DMAC)
Major holders include Leon Cooperman ($13.68 M), Renaissance Technologies (RenTech) ($355,581), Private Capital ($338,500). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.13 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $189,864.92, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DMAC. The total reported sell value was $165,716.08.
Yes, 1 managers opened new positions in DMAC, and 0 increased their existing holdings. The total reported buy value was $355,581.